OpenURL Connection Search - EBSCO

Connecting you to content on EBSCOhost

Select item for more details and to access through your institution.

Pomalidomide in Patients with Interstitial Lung Disease due to Systemic Sclerosis: A Phase II, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study.
Published in:
Journal of Rheumatology, 2018, v. 45, n. 3, p. 405, doi. 10.3899/jrheum.161040
By:
- Hsu, Vivien M.;
- Denton, Christopher P.;
- Domsic, Robyn T.;
- Furst, Daniel E.;
- Rischmueller, Maureen;
- Stanislav, Marina;
- Steen, Virginia D.;
- Distler, Jörg H. W.;
- Korish, Shimon;
- Cooper, Alyse;
- Suktae Choi;
- Schafer, Peter H.;
- Horan, Gerald;
- Hough, Douglas R.
Publication type:
Article
Pomalidomide in Patients with Interstitial Lung Disease due to Systemic Sclerosis: A Phase II, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study.
Published in:
2017
By:
- Hsu, Vivien M;
- Denton, Christopher P;
- Domsic, Robyn T;
- Furst, Daniel E;
- Rischmueller, Maureen;
- Stanislav, Marina;
- Steen, Virginia D;
- Distler, Jörg H W;
- Korish, Shimon;
- Cooper, Alyse;
- Choi, Suktae;
- Schafer, Peter H;
- Horan, Gerald;
- Hough, Douglas R
Publication type:
journal article